Recombinant interleukin-4 (Texas Tech University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant interleukin-4 (Texas Tech University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-4 receptor subunit alpha agonists
TargetsInterleukin-4 receptor subunit alpha
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSouthwest Oncology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSouthwest Oncology
Active IndicationsN/A
Inactive IndicationsCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A